Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.).
1 Main Street, Suite 1350, Cambridge, MA 02142
2016
Delaware
Cullinan Therapeutics’ (formerly Cullinan Oncology) common stock began trading on the NASDAQ Global Select Market under the ticker “CGEM” on January 8, 2021
Cullinan Therapeutics’ common stock is traded on the NASDAQ Global Select Market under the ticker symbol “CGEM,” and its CUSIP # is 230031106
December 31
Computershare Trust Company, N.A.
150 Royall Street, Suite 101
Canton, MA 02021
+1 800.736 3001
+1 781.575.3100
www.computershares.com
Computershare Trust Company, N.A.
150 Royall Street, Suite 101
Canton, MA 02021
+1 800.736 3001
+1 781.575.3100
www.computershares.com
KPMG
Two Financial Center
60 South Street
Boston, MA 02111
+1 617.988.1000
https://www.kpmg.us/
Ropes & Gray
Prudential Tower
800 Boylston Street
Boston, MA 02199-3600
T +1 617 951 7000
https://www.ropesgray.com/
Corporate news releases can be accessed here
SEC filing can be accessed here
Sign up for email alerts from Cullinan Therapeutics here
Cullinan Therapeutics maintains a hotline so that stakeholders are able to report any concerns regarding unsafe conditions or possible policy, ethical or legal violations as it relates to Cullinan Therapeutics. You can access our anonymous form and phone number here.